223
SARS-CoV-2 (COVID-19) Spike RBD Monoclonal Antibody [B001] (Biotin) | 10-553
- SKU:
- 223-10-553-GEN
Description
SARS-CoV-2 (COVID-19) Spike RBD Monoclonal Antibody [B001] (Biotin) | 10-553 | Gentaur UK, US & Europe Distribution
Host: Human
Reactivity: Virus
Homology: N/A
Immunogen: S-RBD recombinant protein
Research Area: Infectious Disease, COVID-19
Tested Application: E, WB, Neut
Application: WB: 1:1000~2000
Specificiy: N/A
Positive Control 1: N/A
Positive Control 2: N/A
Positive Control 3: N/A
Positive Control 4: N/A
Positive Control 5: N/A
Positive Control 6: N/A
Molecular Weight: N/A
Validation: N/A
Isoform: N/A
Purification: Greater than 95% as determined by reducing SDS-PAGE.
Clonality: Monoclonal
Clone: N/A
Isotype: N/A
Conjugate: Biotin
Physical State: Liquid
Buffer: PBS with 0.02% sodium azide, 10% glycerol, pH7.2
Concentration: batch dependent
Storage Condition: Store at 4˚C short term. Aliquot and store at -20˚C long term. Avoid freeze-thaw cycles.
Alternate Name: SARS-CoV-2 (COVID-19, 2019-nCoV) Spike Antibody: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) , Surface Glycoprotein, Spike protein
User Note: Optimal dilutions for each application to be determined by the researcher.
BACKGROUND: SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold to severe diseases. SARS CoV-2 Spike Protein derived from 2019-nCoV is composed of S1 domain and S2 domain. The S1 contains a receptor-binding domain (RBD) that can specifically bind to angiotensin-converting enzyme 2 (ACE2) , the receptor on target cells.